Targeting ROCK signaling in health, malignant and non-malignant diseases

• Published in: Immunology letters 2020-03, Vol.219, p.15-26
• Main Authors: Shahbazi, Roya, Baradaran, Behzad, Khordadmehr, Monireh, Safaei, Sahar, Baghbanzadeh, Amir, Jigari, Farinaz, Ezzati, Hamed
• Format: Article
• Language: English
• Subjects: Cancer therapy; Rho kinase; ROCK inhibitors; ROCK1; ROCK2
• ISSN: 0165-2478; 1879-0542
• DOI: 10.1016/j.imlet.2019.12.012

[Display omitted] •ROCKs play an important role in several physiological and pathological processes.•ROCKs have a principal role in the regulation of actin cytoskeleton dynamics.•Dysregulation of ROCKs is involved in several cardiac pathological processes.•ROCKs can also play a role in controlling of renal function and its disorders.•Overexpression of Rho/ROCK have been indicated in different cancers. A Rho-associated coiled-coil kinase (ROCK) is identified as a critical downstream effector of GTPase RhoA which contains two isoforms, ROCK1 (also known as p160ROCK and ROKβ) and ROCK2 (also known as Rho-kinase and ROKα), the gene of which is placed on chromosomes 18 (18q11.1) and 2 (2p24), respectively. ROCKs have a principal function in the generation of actin-myosin contractility and regulation of actin cytoskeleton dynamics. They represent a chief role in regulating various cellular functions, such as apoptosis, growth, migration, and metabolism through modulation of cytoskeletal actin synthesis, and cellular contraction through phosphorylation of numerous downstream targets. Emerging evidence has indicated that ROCKs present a significant function in cardiac physiology. Of note, dysregulation of ROCKs involves in several cardiac pathological processes like cardiac hypertrophy, cardiac fibrosis, systemic blood pressure disorder, and pulmonary hypertension. Moreover, ROCKs, in addition to their role in regulating renal arteriolar contraction, glomerular blood flow, and filtration, can also play a role in controlling podocytes, tubular cells, and mesangial cell structure and function. Hyperactivity disorder and over-gene expression of Rho/ROCK have been indicated in different cancers. Furthermore, it seems that increasing the expression of mRNA or ROCK protein has an undesirable effect on patient survival and has a positive impact on the progression and worsening of disease prognosis. This review focuses on the physiological and pathological functions of ROCKs with a particular view on its possible value of ROCK inhibitors as a new therapy in cancers and non-cancer diseases.